Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statins before stents: does an ounce of prevention improve outcomes?

× No keyword cloud information.

17 in total

1. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Authors: G G Schwartz; A G Olsson; M D Ezekowitz; P Ganz; M F Oliver; D Waters; A Zeiher; B R Chaitman; S Leslie; T Stern
Journal: JAMA Date: 2001-04-04 Impact factor: 56.272

Review 2. Peri-procedural myocardial injury: 2005 update.

Authors: Joerg Herrmann
Journal: Eur Heart J Date: 2005-09-21 Impact factor: 29.983

3. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.

Authors: Joseph B Selvanayagam; Italo Porto; Keith Channon; Steffen E Petersen; Jane M Francis; Stefan Neubauer; Adrian P Banning
Journal: Circulation Date: 2005-02-21 Impact factor: 29.690

4. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.

Authors: Giuseppe Patti; Massimo Chello; Vincenzo Pasceri; Diego Colonna; Annunziata Nusca; Marco Miglionico; Andrea D'Ambrosio; Elvio Covino; Germano Di Sciascio
Journal: J Am Coll Cardiol Date: 2006-09-26 Impact factor: 24.094

5. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Authors: Vincenzo Pasceri; Giuseppe Patti; Annunziata Nusca; Christian Pristipino; Giuseppe Richichi; Germano Di Sciascio
Journal: Circulation Date: 2004-07-26 Impact factor: 29.690

6. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Authors: Christopher P Cannon; Eugene Braunwald; Carolyn H McCabe; Daniel J Rader; Jean L Rouleau; Rene Belder; Steven V Joyal; Karen A Hill; Marc A Pfeffer; Allan M Skene
Journal: N Engl J Med Date: 2004-03-08 Impact factor: 91.245

7. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

Authors: Giuseppe Patti; Annunziata Nusca; Massimo Chello; Vincenzo Pasceri; Andrea D'Ambrosio; George W Vetrovec; Germano Di Sciascio
Journal: Am J Cardiol Date: 2007-12-21 Impact factor: 2.778

8. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

Authors: Giuseppe Patti; Vincenzo Pasceri; Giuseppe Colonna; Marco Miglionico; Dionigi Fischetti; Gennaro Sardella; Antonio Montinaro; Germano Di Sciascio
Journal: J Am Coll Cardiol Date: 2007-03-27 Impact factor: 24.094

9. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.

Authors: Xin-Wei Jia; Xiang-Hua Fu; Jing Zhang; Xin-Shun Gu; Wei-Ze Fan; Wei-Li Wu; Guo-Zhen Hao; Shi-Qiang Li; Yun-Fa Jiang
Journal: Chin Med J (Engl) Date: 2009-03-20 Impact factor: 2.628

Review 10. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation.

Authors: Dean J Kereiakes
Journal: Circulation Date: 2003-10-21 Impact factor: 29.690